News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (145)
2 (6)
3 (14)
4 (265)
5 (289)
6 (154)
7 (137)
8 (130)
9 (7)
10 (13)
11 (169)
12 (281)
13 (203)
14 (274)
15 (118)
16 (5)
17 (20)
18 (264)
19 (253)
20 (206)
21 (218)
22 (97)
23 (7)
24 (12)
25 (203)
26 (318)
27 (222)
28 (291)
29 (135)
30 (3)
31 (17)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Job Trends
Cerapedics Announces ISASS Bone Grafting Policy Statement Features i-FACTOR™ Peptide Enhanced Bone Graft
Society states company’s drug-device combination technology shown to be safe and effective as autograft replacement with compelling clinical evidence
March 6, 2019
·
3 min read
Biotech Bay
BioMarin to Participate in Cowen and Company 39th Annual Health Care Conference on March 12 in Boston
A replay will be archived on the site for at least one week following each event.
March 6, 2019
·
1 min read
Policy
Water Street’s Partnership with Leading Medical Products Company Leads to FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that its development partnership with a leading medical products company has resulted in the U.S. Food and Drug Administration (FDA) approval and launch of the ready-to-use cardiovascular medication, eptifibatide.
March 6, 2019
·
1 min read
Biotech Bay
UEI College Brings Career Training & Education to Sacramento
Located at 4424 Florin Road in the Southgate Plaza, the new campus is well-equipped with industry standard equipment, hands-on training labs, bright classrooms, and many computer labs.
March 6, 2019
·
3 min read
Biotech Beach
Abarca Receives PBMI Excellence Award for Care Management Strategies
Award recognizes Abarca’s rapid response in the aftermath of Hurricane Maria
March 6, 2019
·
3 min read
Job Trends
Innovative Bed Linen for Neuropathy Sufferers
NeuropathyLinen™ Raises Funds and Pain Awareness on the Crowdfunding Site Indiegogo
March 6, 2019
·
2 min read
Pharm Country
NaBITA Issues Position Statement on Involuntary Withdrawals and the Use of Behavioral Agreements
NaBITA serves as a best practices clearinghouse for over 1,550 members by providing BIT-related model policies, training tools, and templates
March 6, 2019
·
4 min read
Job Trends
WCVC CEO Jim Nixon Brings Personal Passion to Cannabis Partnership With USMJ and PURA
Jim Nixon and his son, Jordon Nixon share their personal, father/son experience with the therapeutic benefits of cannabis when it comes to combating Jordon’s fight with MS.
March 6, 2019
·
3 min read
Deals
Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2027
Exact Sciences Corporation announced today that it has priced its underwritten public offering of 0.3750% convertible senior notes due 2027 (the “Notes”) and upsized the offering from $600 million to $650 million aggregate principal amount.
March 6, 2019
·
5 min read
Policy
FDA Accepts Genentech’s Supplemental New Drug Application for XOFLUZA (baloxavir marboxil) for the Treatment of Influenza in People at High Risk of Complications
XOFLUZA would be the first antiviral medicine approved specifically for the high-risk population
March 6, 2019
·
8 min read
Previous
13 of 16
Next